The result showed that DNMT3A high expression was associated with favorable prognosis in AML patients (log-rank P = 0.002, HR = 0.462, 95%CI = 0.281, 0.759, Figure 1(c)). Here, DNMT3A is linked to acute myeloid leukemia.